Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise


Mental Health

Noven’s flagship product in the mental health area is Daytrana® (methylphenidate transdermal system), the first and only transdermal system approved for ADHD in children and adolescents ages 6-17. Daytrana® is marketed by Noven Therapeutics.

Secuado® (asenapine) transdermal system, the first and only antipsychotic delivered through patch technology in the US for the treatment of schizophrenia in adults, has been added to the Noven mental health portfolio. Secuado® is applied once daily and is available in three dosage strengths.

Daytrana Product Secuado Product

Daytrana Full Prescribing Information

Secuado Full Prescribing Information

More Information

Daytrana® Patient, Physician
and Pharmacist Inquiries:

Tel: 877-567-7857

Secuado® Patient, Physician
and Pharmacist Inquiries:

Tel: Tel: 800-455-8070